| introduction | programme | venue | speakers | delegate list | booking | supporters | sponsors
<
NICE review of brief interventions: what does it mean for you?
Hayden McRobbie, Research Fellow, Clinical Trials Research Unit, School of Population Health, University of Auckland, New Zealand
Abstract
Brief advice to stop smoking works. For every forty people who smoke that are advised to stop by a doctor one will stop smoking long-term who would have otherwise not have managed to do so. Whilst the effect is smaller than more intensive interventions, if delivered to all people who smoke it has great potential to have an impact at a population level.
Brief advice can be given quickly and easily. Assessment of stage of change is unnecessary as advice can be provided to all smokers irrespective of whether they express a wish to stop smoking or not.
Brief advice appears to work by triggering a quit attempt, so wherever possible it should be followed by a recommendation to use pharmacotherapy or referral to a smoking cessation service. The 5A's (ask, advise, assess, assist and arrange) is widely used to promote the provision of smoking cessation advice and treatment. A new memory aid - ABC - has recently been integrated into the New Zealand Smoking Cessation Guidelines. ABC is a simple and easy tool for all healthcare workers to guide their action. It prompts healthcare workers to Ask about smoking status; give Brief advice to stop smoking to all smokers; provide evidence-based Cessation support for those who wish to stop smoking.
Healthcare workers need to be aware of the potential they have to help smokers to stop and ultimately save lives.
Biography
Hayden McRobbie is a medical practitioner with international experience in smoking cessation research and treatment. He studied medicine at the University of Otago, and after graduating in 1996 spend 3 years working though the Auckland Hospitals before heading to London. He worked for six years as a Research Fellow and Senior Clinician at the Tobacco Dependence Research and Treatment Centre at Barts and The London, Queen Mary’s School of Medicine and Dentistry, University of London, where he is also completing his PhD. Recently Hayden has been closely involved in developing guidelines and evidence reviews in smoking cessation for both New Zealand and British agencies. He was one of the lead authors revising and updating the New Zealand Smoking Cessation guidelines for the Ministry of Health, co-authored the English Smoking Cessation Guidelines for Pharmacists for the UK Health Development Agency (now the NHS National Institute of Clinical Excellence, NICE), was an author on the Royal Pharmaceutical Society of Great Britain Patient group directions for the supply of NRT to smokers) and he led a rapid systematic review, commissioned by the National Institute of Clinical Excellence (UK) of Non-NHS treatments for smoking cessation.
He continues his smoking cessation work in New Zealand where his research interests are in finding new ways, both behavioural and pharmacological, to help people who smoke to stop. He also runs a group based Smokers Clinic at the School of Population Health, which helps dependent smokers stop.
Hayden McRobbie
Research Fellow
Clinical Trials Research Unit
The University of Auckland
Auckland
1005
New Zealand
| |
|
